As of now, Poland reports a research & development by business enterprise, pharmaceutical industry in constant ppp $ of 249.57 million, signifying an increase of 69.16 million (38.3%) from 2020.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Poland
No matching regions
Similar regions to Poland
Business R&D pharmaceutical in constant PPP $
More indicators for Poland
Government R&D in security as % of government support
4.13%
+0.82%
(2021)
Higher-education-finacing R&D financed by general university in local currency
60,574.85M
+13,304.51M
(2021)
R&D financed by rest of the world in local currency
30,791.22M
+7,537.32M
(2021)
Government R&D financed by rest of the world in local currency
938.25M
+346.95M
(2021)
Business R&D financed by rest of the world in local currency
18,960.22M
+4,066.30M
(2021)
Non-profit R&D growth rate
1.18%
+8.51%
(2022)
Poland Business R&D pharmaceutical in constant PPP $ between 2005 and 2021
| Period | Business R&D pharmaceutical in constant PPP $ | Change |
|---|---|---|
| 2021 | 249.57M | +69.16M |
| 2020 | 180.41M | -67.84M |
| 2019 | 248.24M | -43.27M |
| 2018 | 291.51M | +36.76M |
| 2017 | 254.76M | +78.32M |
| 2016 | 176.43M | -39.47M |
| 2015 | 215.91M | +63.05M |
| 2014 | 152.86M | +28.06M |
| 2013 | 124.79M | -24.84M |
| 2012 | 149.63M | +50.79M |
| 2011 | 98.84M | +4.23M |
| 2010 | 94.61M | -3.89M |
| 2009 | 98.50M | -21.20M |
| 2008 | 119.70M | +36.77M |
| 2007 | 82.93M | -1.70M |
| 2006 | 84.63M | -8.71M |
| 2005 | 93.34M |